Dr. Jaime Antonio Tschen, MD

Dr. Tschen practices at St. Joseph Dermatopathology in Houston, Texas.

Dr. Tschen's NPI, 1164527800, was assigned on September 14, 2006. Dr. Tschen graduated from Universidad de San Carlos FOMS in 1975. Dr. Tschen holds Texas license E8980.

Dr. Tschen's primary practice is St. Joseph Dermatopathology, at 6909 Greenbriar St, Houston, TX 77030. The practice phone is (713) 660-9444.

Dr. Tschen's primary practice is St. Joseph Dermatopathology in Houston, Texas. The medical group on file is St. Joseph Dermatopathology. Dmand AI also links Dr. Tschen to 1 more clinical lab, named with a free account. Dr. Tschen's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tschen practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Tschen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Tschen is board certified in dermatology by the American Board of Dermatology. Dr. Tschen is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, hives and psoriasis among the conditions Dr. Tschen treats.

CMS data shows 1,591 Medicare services from Dr. Tschen across 14 procedure codes in 2024, for 407 Medicare patients. Medicare paid $77,108 for them. Every service was in an office.

CMS counts 407 Medicare patients who saw Dr. Tschen in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tschen's median patient age at 63, with 52% women.

In 2024, Dr. Tschen wrote 590 Medicare Part D claims for 202 patients. 88% of them were for generic drugs. CMS names the drug for 448 of them, across 15 drugs with 11 or more claims each, at $112,143 in total drug cost. In 2023, CMS named 325 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tschen for performance year 2024, reported individually. Dr. Tschen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 630 procedures of removal of skin lesions by Dr. Tschen, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 175 papers to Dr. Tschen, published from 2007 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Skin and Diagnosis, Differential. Dr. Tschen has published most often in Arch Dermatol. Dr. Tschen's most frequent co-authors are Philip R. Cohen, MD, Bruce R. Nelson, MD and Tejas Joshi, MD.

CMS Open Payments shows 248 general payments to Dr. Tschen from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Sanofi and Genzyme US Companies paid the most, $780.

Dmand AI lists 4 awards for Dr. Tschen, most recently Checkbook Top Doc in 2013.

Dr. Tschen graduated from Universidad de San Carlos FOMS in 1975. Dr. Tschen is a member of AAD.

Dr. Tschen is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.